Dosage forms providing controlled and immediate release of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/20 (2006.01) A61K 9/50 (2006.01) A61K 31/40 (2006.01) A61K 31/4706 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2601762

A dosage form that includes a cholesteryl ester transfer protein inhibitor in a solubility-improved form and an HMG-CoA reductase inhibitor, wherein the dosage form provides immediate release of the HMG-CoA reductase inhibitor and controlled release and immediate release of the cholesteryl ester transfer protein inhibitor.

La présente invention a trait à une forme de dosage comportant un inhibiteur de protéines de transfert d'ester de cholestéryle sous une forme à solubilité améliorée et un inhibiteur de HMG-CoA réductase, ladite forme de dosage assurant la libération instantanée de l'inhibiteur de HMG-CoA réductase et la libération contrôlée et la libération instantanée de l'inhibiteur des protéines de transfert d'ester de cholestéryle

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dosage forms providing controlled and immediate release of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dosage forms providing controlled and immediate release of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage forms providing controlled and immediate release of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1814326

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.